Literature DB >> 33207226

Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.

Hiroaki Kasashima1, Angeles Duran1, Anxo Martinez-Ordoñez2, Yuki Nakanishi3, Hiroto Kinoshita1, Juan F Linares2, Miguel Reina-Campos3, Yotaro Kudo3, Antoine L'Hermitte3, Masakazu Yashiro4, Masaichi Ohira4, Fei Bao5, Daniele V F Tauriello6, Eduard Batlle7, Maria T Diaz-Meco8, Jorge Moscat9.   

Abstract

Cancer-associated fibroblasts (CAFs) promote tumor malignancy, but the precise transcriptional mechanisms regulating the acquisition of the CAF phenotype are not well understood. We show that the upregulation of SOX2 is central to this process, which is repressed by protein kinase Cζ (PKCζ). PKCζ deficiency activates the reprogramming of colonic fibroblasts to generate a predominant SOX2-dependent CAF population expressing the WNT regulator Sfrp2 as its top biomarker. SOX2 directly binds the Sfrp1/2 promoters, and the inactivation of Sox2 or Sfrp1/2 in CAFs impaired the induction of migration and invasion of colon cancer cells, as well as their tumorigenicity in vivo. Importantly, recurrence-free and overall survival of colorectal cancer (CRC) patients negatively correlates with stromal PKCζ levels. Also, SOX2 expression in the stroma is associated with CRC T invasion and worse prognosis of recurrence-free survival. Therefore, the PKCζ-SOX2 axis emerges as a critical step in the control of CAF pro-tumorigenic potential.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CMS4; PKCz; SFRP; SOX2; TGFβ; atypical PKCs; cancer-associated fibroblasts; colorectal cancer; metastasis; stroma

Mesh:

Substances:

Year:  2020        PMID: 33207226      PMCID: PMC7856011          DOI: 10.1016/j.devcel.2020.10.014

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  54 in total

1.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

2.  Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis.

Authors:  Li Ma; Yongzhen Tao; Angeles Duran; Victoria Llado; Anita Galvez; Jennifer F Barger; Elias A Castilla; Jing Chen; Tomoko Yajima; Aleksey Porollo; Mario Medvedovic; Laurence M Brill; David R Plas; Stefan J Riedl; Michael Leitges; Maria T Diaz-Meco; Adam D Richardson; Jorge Moscat
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

Review 3.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

Review 4.  The sox family of transcription factors: versatile regulators of stem and progenitor cell fate.

Authors:  Abby Sarkar; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2013-01-03       Impact factor: 24.633

5.  Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer.

Authors:  Hae-Ock Lee; Yourae Hong; Hakki Emre Etlioglu; Yong Beom Cho; Valentina Pomella; Ben Van den Bosch; Jasper Vanhecke; Sara Verbandt; Hyekyung Hong; Jae-Woong Min; Nayoung Kim; Hye Hyeon Eum; Junbin Qian; Bram Boeckx; Diether Lambrechts; Petros Tsantoulis; Gert De Hertogh; Woosung Chung; Taeseob Lee; Minae An; Hyun-Tae Shin; Je-Gun Joung; Min-Hyeok Jung; Gunhwan Ko; Pratyaksha Wirapati; Seok Hyung Kim; Hee Cheol Kim; Seong Hyeon Yun; Iain Bee Huat Tan; Bobby Ranjan; Woo Yong Lee; Tae-You Kim; Jung Kyoon Choi; Young-Joon Kim; Shyam Prabhakar; Sabine Tejpar; Woong-Yang Park
Journal:  Nat Genet       Date:  2020-05-25       Impact factor: 38.330

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.

Authors:  Anne Trinh; Kari Trumpi; Felipe De Sousa E Melo; Xin Wang; Joan H de Jong; Evelyn Fessler; Peter J K Kuppen; Marlies S Reimers; Marloes Swets; Miriam Koopman; Iris D Nagtegaal; Marnix Jansen; Gerrit K J Hooijer; George J A Offerhaus; Onno Kranenburg; Cornelis J Punt; Jan Paul Medema; Florian Markowetz; Louis Vermeulen
Journal:  Clin Cancer Res       Date:  2016-07-26       Impact factor: 12.531

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

10.  Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.

Authors:  Rene Jackstadt; Sander R van Hooff; Joshua D Leach; Xabier Cortes-Lavaud; Jeroen O Lohuis; Rachel A Ridgway; Valérie M Wouters; Jatin Roper; Timothy J Kendall; Campbell S Roxburgh; Paul G Horgan; Colin Nixon; Craig Nourse; Matthias Gunzer; William Clark; Ann Hedley; Omer H Yilmaz; Mamunur Rashid; Peter Bailey; Andrew V Biankin; Andrew D Campbell; David J Adams; Simon T Barry; Colin W Steele; Jan Paul Medema; Owen J Sansom
Journal:  Cancer Cell       Date:  2019-09-16       Impact factor: 38.585

View more
  13 in total

Review 1.  Taking the road less traveled - the therapeutic potential of CBP/β-catenin antagonists.

Authors:  Michael Kahn
Journal:  Expert Opin Ther Targets       Date:  2021-10-27       Impact factor: 6.902

2.  SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer.

Authors:  Siyuan Weng; Zaoqu Liu; Xiaofeng Ren; Hui Xu; Xiaoyong Ge; Yuqing Ren; Yuyuan Zhang; Qin Dang; Long Liu; Chunguang Guo; Richard Beatson; Jinhai Deng; Xinwei Han
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

3.  The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62.

Authors:  Juan F Linares; Tania Cid-Diaz; Angeles Duran; Marta Osrodek; Anxo Martinez-Ordoñez; Miguel Reina-Campos; Hui-Hsuan Kuo; Olivier Elemento; M Laura Martin; Thekla Cordes; Timothy C Thompson; Christian M Metallo; Jorge Moscat; Maria T Diaz-Meco
Journal:  Cell Rep       Date:  2022-05-10       Impact factor: 9.995

4.  PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.

Authors:  Juan F Linares; Xiao Zhang; Anxo Martinez-Ordoñez; Angeles Duran; Hiroto Kinoshita; Hiroaki Kasashima; Naoko Nakanishi; Yuki Nakanishi; Ryan Carelli; Luca Cappelli; Esperanza Arias; Masakazu Yashiro; Masaichi Ohira; Sanjay Patel; Giorgio Inghirami; Massimo Loda; Ana Maria Cuervo; Maria T Diaz-Meco; Jorge Moscat
Journal:  Mol Cell       Date:  2021-09-23       Impact factor: 17.970

5.  Mouse model of colorectal cancer: orthotopic co-implantation of tumor and stroma cells in cecum and rectum.

Authors:  Hiroaki Kasashima; Angeles Duran; Tania Cid-Diaz; Yu Muta; Hiroto Kinoshita; Eduard Batlle; Maria T Diaz-Meco; Jorge Moscat
Journal:  STAR Protoc       Date:  2021-01-22

Review 6.  Minimal Residual Disease, Metastasis and Immunity.

Authors:  Jordi Badia-Ramentol; Jenniffer Linares; Andrea Gómez-Llonin; Alexandre Calon
Journal:  Biomolecules       Date:  2021-01-20

7.  Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.

Authors:  Cong Wang; Chuzhi Shang; Xiaohong Gai; Tao Song; Shaoshan Han; Qingguang Liu; Xin Zheng
Journal:  Front Cell Dev Biol       Date:  2021-04-06

8.  Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling.

Authors:  Ling-Fang Gao; Yan Zhong; Ting Long; Xia Wang; Jia-Xian Zhu; Xiao-Yan Wang; Zhi-Yan Hu; Zu-Guo Li
Journal:  J Exp Clin Cancer Res       Date:  2022-03-03

Review 9.  Modeling the Role of Cancer-Associated Fibroblasts in Tumor Cell Invasion.

Authors:  Stephanie Poon; Laurie E Ailles
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

Review 10.  Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy.

Authors:  Hans Raskov; Adile Orhan; Shruti Gaggar; Ismail Gögenur
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.